Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 1958 entries
View as:

Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT02605174 Org: User:
Start: 05/31/16 End: 06/30/17 Due: 06/30/18

A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT06824051 Org: User:
Start: 02/17/25 End: 12/31/25 Due: 12/31/26

A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT06683508 Org: User:
Start: 11/13/24 End: 09/30/26 Due: 09/30/27

Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01199822 Org: User:
Start: 09/30/10 End: 01/31/12 Due: 01/31/13

A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Phase: N/A Priority: Normal
NCT ID: NCT02614131 Org: User:
Start: 12/31/15 End: 12/31/16 Due: 12/31/17

Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00386581 Org: User:
Start: 07/31/04 End: 02/28/05 Due: 02/28/06

A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices

Phase: N/A Priority: Normal
NCT ID: NCT05810597 Org: User:
Start: 04/03/23 End: 07/17/23 Due: 07/17/24

A Study of LY3502970 in Healthy Overweight and Obese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05313802 Org: User:
Start: 05/26/22 End: 09/09/22 Due: 09/09/23

Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00191659 Org: User:
Start: 06/30/04 End: 04/30/06 Due: 04/30/07

Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC

Phase: N/A Priority: Normal
NCT ID: NCT00236899 Org: User:
Start: 09/30/05 End: 08/31/10 Due: 08/31/11

A Study of LY2835219 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02256267 Org: User:
Start: 10/31/14 End: 11/30/14 Due: 11/30/15

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

Phase: N/A Priority: Normal
NCT ID: NCT02008357 Org: User:
Start: 02/28/14 End: 06/08/23 Due: 06/08/24

A Study of How the Body Breaks Down and Eliminates LY2623091

Phase: N/A Priority: Normal
NCT ID: NCT02242981 Org: User:
Start: 09/30/14 End: 11/30/14 Due: 11/30/15

A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00781911 Org: User:
Start: 02/28/09 End: 05/31/16 Due: 05/31/17

A Study of LY3041658 in Participants With Skin Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02896868 Org: User:
Start: 11/08/16 End: 03/19/19 Due: 03/19/20

A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05440136 Org: User:
Start: 06/28/22 End: 03/08/23 Due: 03/08/24

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT02708095 Org: User:
Start: 03/24/16 End: 11/09/17 Due: 11/09/18

A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS

Phase: N/A Priority: Normal
NCT ID: NCT04517253 Org: User:
Start: 10/27/20 End: 11/28/24 Due: 11/28/25

A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide

Phase: N/A Priority: Normal
NCT ID: NCT04081337 Org: User:
Start: 07/09/20 End: 05/26/22 Due: 05/26/23

A Study of LY3461767 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04352114 Org: User:
Start: 06/15/20 End: 01/13/21 Due: 01/13/22

Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00391274 Org: User:
Start: 10/31/06 End: 06/30/10 Due: 06/30/11

Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00231725 Org: User:
Start: 09/30/05 End: 04/30/06 Due: 04/30/07

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03882970 Org: User:
Start: 04/01/19 End: 01/04/21 Due: 01/04/22

A Study of LY2940680 in Japanese Participants With Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01919398 Org: User:
Start: 08/31/13 End: 06/28/17 Due: 06/28/18

Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine

Phase: N/A Priority: Normal
NCT ID: NCT00401973 Org: User:
Start: 11/30/06 End: 09/30/08 Due: 09/30/09